FdaApplication

ANDA 209953

Back to search

Identifiers

Properties

PropertyValue
applicant_nameALKEM LABORATORIES LTD
application_typeANDA
approval_date2020-11-30

Products (2)

ProductActive ingredientStrengthDosage form
RANOLAZINERANOLAZINE500MGTABLET, EXTENDED RELEASE;ORAL
RANOLAZINERANOLAZINE1GMTABLET, EXTENDED RELEASE;ORAL

2 products